Search - tctmd.com

Displaying 541 - 560 of 747

Sort: Relevancy | Date

News Daily News

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

September 05, 2012

News Daily News

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

September 05, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

August 26, 2012

News Daily News

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Yael L. Maxwell

August 23, 2012

News Daily News

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Yael L. Maxwell

August 17, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Daily News

Meta-analysis: Triple Therapy with Cilostazol Lowers TLR, TVR With No Extra Bleeding

Jason Kahn

July 13, 2012

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Daily News

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

June 29, 2012

News Daily News

La Colocación de un Stent en la Arteria Carótida a la Semana de cursar los Primeros Síntomas acarrea Más Riegos que la CEA

Jason Kahn

June 12, 2012

News Daily News

Carotid Stenting Within First Week of Symptoms Carries Higher Risk Than CEA

Jason Kahn

June 12, 2012

News Daily News

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

May 25, 2012

Advertisement

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Xience V Noninferior to Cypher for Primary PCI

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

Meta-analysis: Triple Therapy with Cilostazol Lowers TLR, TVR With No Extra Bleeding

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

DES Show More Neoatherosclerosis Than BMS Over 4 Years

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

La Colocación de un Stent en la Arteria Carótida a la Semana de cursar los Primeros Síntomas acarrea Más Riegos que la CEA

Carotid Stenting Within First Week of Symptoms Carries Higher Risk Than CEA

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content